PUBLICACIONES

Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis
Source: Alberto Borobia Published on 2026-08-05
Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis
Source: Alberto Borobia Published on 2026-08-05
Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis
Source: Alberto Borobia Published on 2026-08-05
Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis
Source: Alberto Borobia Published on 2026-08-05
Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis
Source: Alberto Borobia Published on 2026-08-05
Pre-emptive CYP2C19 genotyping and voriconazole exposure in pediatric hematology patients at risk of aspergillosis: an exploratory randomized pilot study with a cost-consequence analysis
Source: Alberto Borobia Published on 2026-08-05
Multicentre, controlled, randomised and single-blind, adaptive phase IV protocol to evaluate effectiveness and cost-effectiveness of a pre-emptive genotyping strategy to optimise tacrolimus dosage in a pretransplant chronic kidney disease population cohort: iPHARMGx TRANSPGx nested clinical trial
Source: Alberto Borobia Published on 2026-08-03
Feasibility and safety profile of intranasal third-party allogeneic CD45RO+/RA- memory T cells: a phase I clinical trial (vRELEASE-I NCT06699758)
Source: Alberto Borobia Published on 2026-07-23
Integrating pharmacogenetic and clinical factors to predict the C0/D/W-based tacrolimus phenotype in kidney transplantation
Source: Alberto Borobia Published on 2026-06-01
Prognostic Value of Lung Injury Biomarkers in Patients Hospitalized With COVID-19 Without Respiratory Failure at Admission
Source: Alberto Borobia Published on 2026-05-26
MesenSistem-EB: systemic haploidentical mesenchymal stem cell therapy in recessive dystrophic epidermolysis bullosa associated with clinical benefits and correlated with MCP1 and sCD40L dynamics
Source: Alberto Borobia Published on 2026-05-21
Pharmacogenetic biomarkers for predicting therapeutic response to JAK inhibitors in rheumatoid arthritis
Source: Alberto Borobia Published on 2026-05-15
Combined Oral Contraceptive Drug-Drug Interaction Study With Ganfeborole, a New Anti-Tuberculosis Agent
Source: Alberto Borobia Published on 2026-03-07
Safety and immunogenicity of an investigational mRNA-lipid nanoparticle-based monovalent influenza vaccine: Results from a phase 1, randomized, dose-escalation study
Source: Alberto Borobia Published on 2026-02-17
Genetic patterns related to von Willebrand factor: implications on the need for mechanical ventilation, severity, and death in COVID-19
Source: Alberto Borobia Published on 2026-01-26

Hospital Universitario La Paz

Servicio de Farmacología Clínica – UCICEC

Horario:

Lunes a Jueves 8.00-17.00

Viernes 8.00 - 15.00

Teléfono: 91 207 14 66

Fax: 91 207 13 84

Email: ucicec.hulp@salud.madrid.org